Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena
Roche reports positive Phase III data of giredestrant for breast cancer Clinical Trials Arena
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
Roche sizes up first BTK inhibitor approval on Phase III MS victory Clinical Trials Arena
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint Clinical Trials Arena